Cargando…
The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis
Nanoparticles for colon-drug delivery were designed and evaluated to solve many discrepancy issues such as high adverse effects of released drugs, insufficient drug amount at diseased areas, and unintentionally premature drug release to noninflamed GIT regions. Herein, the goal of this work was to c...
Autores principales: | Motawea, Amira, Abd El Hady, Walaa Ebrahim, Ahmed El-Emam, Ghada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933020/ https://www.ncbi.nlm.nih.gov/pubmed/35297699 http://dx.doi.org/10.1080/10717544.2022.2050847 |
Ejemplares similares
-
The Idiosyncratic Efficacy of Spironolactone-Loaded PLGA Nanoparticles Against Murine Intestinal Schistosomiasis
por: Abd El Hady, Walaa Ebrahim, et al.
Publicado: (2023) -
Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2021) -
Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly
por: Zhou, Yeping, et al.
Publicado: (2022) -
Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial
por: Kountouras, Jannis, et al.
Publicado: (2020) -
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis
por: Deng, Jianping, et al.
Publicado: (2020)